| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10217863 | Clinical Gastroenterology and Hepatology | 2018 | 45 Pages |
Abstract
In a systematic review and meta-analysis, we found μ-opioid-receptor antagonists to be safe and effective for the treatment of OIC. Prescription-strength laxatives (prucalopride, lubiprostone) are slightly better than placebo in reducing OIC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Judy Nee, Mohammed Zakari, Michael A. Sugarman, Julia Whelan, William Hirsch, Shahnaz Sultan, Sarah Ballou, Johanna Iturrino, Anthony Lembo,